Research from Lund University in Sweden shows that the protein COMP, which mainly exists in cartilage, can also be found in breast cancer tumours in patients with a poor prognosis. Studies on mice also showed that COMP contributed to the development and metastasis of the breast cancer.
COMP (Cartilage Oligomeric Matrix Protein) is a protein that so far has mainly been studied in cartilage tissue, where it helps development of a normal structure of the tissue. COMP is also used as an indicator of cartilage damage in joint diseases.
High expression of COMP in breast cancer cells, seen here in brown, is associated with poor clinical prognosis for the patient. Cancer cells expressing COMP become more invasive and change their metabolism, which allows them to survive better and spread to other organs.
Photo: Anna Bloms / Lund University
Through a database search, the research group at Lund University discovered a clue that sparked their interest in studying whether COMP may also be linked to breast cancer.
"We did not expect to find COMP in connection with breast cancer, and we were also surprised by the strong effect it had on the development of breast cancer in mice", says Emelie Englund, Doctor of Medical Science at the Department of Translational Medicine at Lund University.
The results are based on a clinical study of breast tissue from a little more than 600 women with breast cancer. Various amounts of COMP were found in both the tumours and the surrounding tissue, but never in healthy breast tissue. Women with high levels of COMP experienced increased metastasis, less time before a relapse, and increased mortality.
"We saw a clear association between high levels of COMP and a worse breast cancer prognosis. With more research, COMP has the potential of becoming an indicator of aggressive breast cancer, and thereby providing early and valuable information before deciding on an appropriate treatment", says Anna Blom, Professor in Protein Chemistry at Lund University.
Following the clinical study, the research group continued with studies on the molecular mechanisms that may explain the effect COMP has on the breast cancer development. The studies, including one on mice, showed that COMP not only contributed to a more rapid growth of the primary tumour, but also to formation of metastases. COMP made the cancer cells more resistant to natural cell death, as well as affected the cell metabolism, making the breast environment less favourable to healthy cells.
The research group is now initiating advanced studies on COMP and the molecular processes that take place during cell metabolism. They are also conducting studies on other changed cellular processes linked to COMP and tumour formation in the breast. Preliminary discoveries indicate that the protein may be significant in terms of the development of prostate cancer as well.
The results are published in the American journal Oncogene. The research is funded by the Swedish Cancer Society, the Malmö Hospital Foundation for Fighting Against Cancer, the Swedish Research Council and through so-called ALF funding for clinical research, among others.
Publication: "Cartilage Oligomeric Matrix Protein (COMP) Contributes to the Development and Metastasis of Breast Cancer"
Authors: Emelie Englund (fmr Holmquist), Michael Bartoschek, Bart Reitsma, Laila Jacobsson, Astrid Escudero-Esparza, Akira Orimo, Karin Leandersson, Catharina Hagerling, Anders Aspberg, Petter Storm, Marcin Okroj, Hindrik Mulder, Karin Jirström, Kristian Pietras and Anna M. Blom. Oncogene published online 11 April 2016; doi: 10.1038/onc.2016.98
Breast cancer is the most common form of cancer among women, with more than 7 000 new cases in Sweden every year. Nowadays patients have a good chance of survival, but the treatment is often associated with major consequences and suffering for the patient, following medication, radiation therapy and surgery.
Anna Blom, Professor in Protein Chemistry, Department of Translational Medicine, Lund University,
Tel: +46 (0)40-33 82 33, 070-415 06 82
Cecilia Schubert | EurekAlert!
Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku
Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy